Nectar Lifesciences Shares Price Jump 12% Ahead of Board Meeting to Approve Financial Results

Chandigarh, November 13, 2025: The share price of Nectar Lifesciences closed with a surge of 12% on Thursday, ahead of its upcoming Board meeting scheduled for Friday, November 14, 2025. The company announced that the Board will review and approve the unaudited financial results for the quarter and half-year ended September 30, 2025. It added that the meeting will also deliberate on other key business matters.

Share Price Update

Nectar Lifesciences Ltd opened at ₹13.51 and climbed to an intraday high of ₹16.50, before touching a low of ₹13.51. The company’s market capitalisation stands at ₹354.51 crore. Over the past 52 weeks, the stock has traded between ₹13.05 and ₹44.41. Total traded volume for the day was 27.83 lakh shares, amounting to a turnover of ₹437.16 lakh, with a VWAP of ₹15.80.

On the performance front, Nectar Lifesciences shares have fallen 60% year-to-date and 30% over the past six months, though they have gained 14% in the last month and 13% in the past five days, indicating a short-term recovery trend.

Nectar Lifesciences Limited is a listed pharmaceutical company. It is engaged in the production of active pharmaceutical ingredients, intermediates, and formulations. The company is listed on NSE and BSE. Nectar Lifesciences Limited operates from its registered office in Punjab.

REF: https://nsearchives.nseindia.com/corporate/NECLIFE_09112025144049_Notice_BM_Notice_251114_Signed.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations